Literature DB >> 22143532

Molecular analyses of TEM genes and their corresponding penicillinase-producing Neisseria gonorrhoeae isolates in Bangkok, Thailand.

Shu-Ichi Nakayama1, Chanwit Tribuddharat, Sasiprapa Prombhul, Ken Shimuta, Somporn Srifuengfung, Magnus Unemo, Makoto Ohnishi.   

Abstract

Neisseria gonorrhoeae is a major public health problem globally, especially because the bacterium has developed resistance to most antimicrobials introduced for first-line treatment of gonorrhea. In the present study, 96 N. gonorrhoeae isolates with high-level resistance to penicillin from 121 clinical isolates in Thailand were examined to investigate changes related to their plasmid-mediated penicillin resistance and their molecular epidemiological relationships. A β-lactamase (TEM) gene variant, bla(TEM-135), that may be a precursor in the transitional stage of a traditional bla(TEM-1) gene into an extended-spectrum β-lactamase (ESBL), possibly causing high resistance to all extended-spectrum cephalosporins in N. gonorrhoeae, was identified. Clonal analysis using multilocus sequence typing (MLST) and N. gonorrhoeae multiantigen sequence typing (NG-MAST) revealed the existence of a sexual network among patients from Japan and Thailand. Molecular analysis of the bla(TEM-135) gene showed that the emergence of this allele might not be a rare genetic event and that the allele has evolved in different plasmid backgrounds, which results possibly indicate that it is selected due to antimicrobial pressure. The presence of the bla(TEM-135) allele in the penicillinase-producing N. gonorrhoeae population may call for monitoring for the possible emergence of ESBL-producing N. gonorrhoeae in the future. This study identified a bla(TEM) variant (bla(TEM-135)) that is a possible intermediate precursor for an ESBL, which warrants international awareness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22143532      PMCID: PMC3264274          DOI: 10.1128/AAC.05665-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs.

Authors:  Xiaojun Wang; George Minasov; Brian K Shoichet
Journal:  J Mol Biol       Date:  2002-06-28       Impact factor: 5.469

Review 2.  The Gonococcus fights back: is this time a knock out?

Authors:  David A Lewis
Journal:  Sex Transm Infect       Date:  2010-07-23       Impact factor: 3.519

3.  Identification of TEM-135 beta-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan.

Authors:  Makoto Ohnishi; Emi Ono; Ken Shimuta; Haruo Watanabe; Noboru Okamura
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

Review 4.  Emergence and spread of drug resistant Neisseria gonorrhoeae.

Authors:  Takashi Deguchi; Keita Nakane; Mitsuru Yasuda; Shin-ichi Maeda
Journal:  J Urol       Date:  2010-09       Impact factor: 7.450

Review 5.  Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies.

Authors:  John Tapsall
Journal:  Expert Rev Anti Infect Ther       Date:  2006-08       Impact factor: 5.091

6.  Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone.

Authors:  Makoto Ohnishi; Daniel Golparian; Ken Shimuta; Takeshi Saika; Shinji Hoshina; Kazuhiro Iwasaku; Shu-ichi Nakayama; Jo Kitawaki; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

7.  Physical linkage of Tn3 and part of Tn1721 in a tetracycline and ampicillin resistance plasmid from Salmonella Typhimurium.

Authors:  Frédérique Pasquali; Corinna Kehrenberg; Gerardo Manfreda; Stefan Schwarz
Journal:  J Antimicrob Chemother       Date:  2005-02-24       Impact factor: 5.790

8.  Characterization of a novel β-lactamase-producing plasmid in Neisseria gonorrhoeae: sequence analysis and molecular typing of host gonococci.

Authors:  Etienne E Müller; Samuel A Fayemiwo; David A Lewis
Journal:  J Antimicrob Chemother       Date:  2011-04-26       Impact factor: 5.790

9.  Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-seropositive patients and gonococcal antimicrobial susceptibility: an update in Thailand.

Authors:  Somporn Srifeungfung; Anuvat Roongpisuthipong; Suvanna Asavapiriyanont; Rangsima Lolekha; Chanwit Tribuddharat; Somchai Lokpichart; Prasong Sungthong; Patrapee Tongtep
Journal:  Jpn J Infect Dis       Date:  2009-11       Impact factor: 1.362

10.  Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.

Authors:  Makoto Ohnishi; Takeshi Saika; Shinji Hoshina; Kazuhiro Iwasaku; Shu-ichi Nakayama; Haruo Watanabe; Jo Kitawaki
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

View more
  19 in total

1.  Penicillinase-producing plasmid types in Neisseria gonorrhoeae clinical isolates from Australia.

Authors:  David Whiley; Ella Trembizki; Cameron Buckley; Kevin Freeman; Andrew Lawrence; Athena Limnios; Julie Pearson; Helen Smith; Kerrie Stevens; Monica M Lahra
Journal:  Antimicrob Agents Chemother       Date:  2014-09-29       Impact factor: 5.191

Review 2.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Identification of TEM-135 β-lactamase in Neisseria gonorrhoeae strains carrying African and Toronto plasmids in Argentina.

Authors:  R Gianecini; C Oviedo; A Littvik; E Mendez; L Piccoli; S Montibello; P Galarza
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

Review 4.  Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance.

Authors:  Namraj Goire; Monica M Lahra; Marcus Chen; Basil Donovan; Christopher K Fairley; Rebecca Guy; John Kaldor; David Regan; James Ward; Michael D Nissen; Theo P Sloots; David M Whiley
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

5.  Characterization of a novel Neisseria gonorrhoeae penicillinase-producing plasmid isolated in Australia in 2012.

Authors:  Ella Trembizki; Cameron Buckley; Andrew Lawrence; Monica Lahra; David Whiley
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

Review 6.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

7.  In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?

Authors:  Magnus Unemo; Daniel Golparian; Athena Limnios; David Whiley; Makoto Ohnishi; Monica M Lahra; John W Tapsall
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

8.  New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan.

Authors:  Shu-Ichi Nakayama; Ken Shimuta; Kei-Ichi Furubayashi; Takuya Kawahata; Magnus Unemo; Makoto Ohnishi
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

9.  Azithromycin resistance is coevolving with reduced susceptibility to cephalosporins in Neisseria gonorrhoeae in Ontario, Canada.

Authors:  Vanessa G Allen; Christine Seah; Irene Martin; Roberto G Melano
Journal:  Antimicrob Agents Chemother       Date:  2014-02-10       Impact factor: 5.191

10.  Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.

Authors:  Andrea Endimiani; Yuvia N Guilarte; Regula Tinguely; Lea Hirzberger; Sylvia Selvini; Agnese Lupo; Christoph Hauser; Hansjakob Furrer
Journal:  BMC Infect Dis       Date:  2014-02-25       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.